REG - MD Medical Group - MDMG ANNOUNCES LISTING ON THE MOSCOW EXCHANGE

MD Medical InvestmentsAnnouncement

05/11/2020 17:45

RNS Number : 4427E
  
MD Medical Group Investments PLC
  
05 November 2020
  
 

 
MD MEDICAL GROUP ANNOUNCES LISTING ON THE MOSCOW EXCHANGE
5 November 2020, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces that it has received approval for the listing of the Company's Global Depositary Receipts (GDRs) (ISIN US55279C2008) on the MOEX and their inclusion into the Level 1 quotation list. The first day of trading is scheduled for November 9 2020. The trading ticker is MDMG. Quotation will be done in Russian rubles.
The listing on the Moscow Exchange will be done of the MD Medical Group Investments Plc shares in the form of GDRs which currently trade on the London Stock Exchange. The listing in Moscow does not require an issue of new shares and will allow the Company's existing GDRs to be traded also on the Moscow Exchange. 
Neither the Company, nor its shareholders are not placing GDRs and this release is not an offer to buy or sell the shares of the Company.  
 
It is expected that the listing on the Moscow Exchange will provide the Company access to a broader pool of investors, including Russian institutional and retail investors, who are well familiar with the Company's brand. The Company expects that the listing will promote liquidity of the GDRs on both trading platforms.
 
The ceremony, launching the start of trading with the participation of the CEO of MD Medical Group Mark Kurtser and top executives from the Moscow Exchange, will take place on November 9 2020 at 9-45 Moscow time and will be broadcast on the MOEX website.
 
 
 
 
For further information please contact:



Investors


Media




            
Dmitry Yakushkin 
MD Medical Group Investments Plc
Tel: +7 (495) 139-87-40, ext. 16329

d.yakushkin@mcclinics.ru


EM

Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
MDMG@em-comms.com



About MD Medical Group
 
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
 
Forward-Looking Statements:
 
This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCUVUBRRKUARAA